← All reports
Friday, November 6, 2026 · after the close

Chip stocks bounced and a strong jobs report lifted the Nasdaq, so we gained 0.7% against the S&P's 0.3%. The week still cost us 4.9% against 2.7% for the S&P, because our AI-heavy funds took the brunt of Thursday's sell-off.

Today
+0.7%
S&P 500 +0.3%
Since Sep 24
−6.6%
S&P 500 −4.1%
Vs the S&P
−2.5 pts
since Sep 24
Cash
19.5%
of the account

The account vs the market

Account
Total return from the start of the range, after fees. Hover, tap or use the arrow keys to read a day.

What moved the market

The trigger: a strong jobs report

The economy added 165,000 jobs in October against about 65,000 expected. Wages rose 0.4% in the month and unemployment slipped to 4.1% (Schwab). That is good news for the economy, but it keeps the Fed leaning toward a rate hike in December: markets put the odds near 73%.

How it played out on Friday

S&P 500 (SPY)+0.3%
Nasdaq-100 (QQQ)+1.4%
Dow−0.5%
World stocks (VT)+0.2%
Chip fund (SMH)+3.6%
TSM+6.3%
NVDA+2.8%
Halozyme (HALO, on our watch list)−15.7%

Why the bounce faded

Where it stands

The S&P lost 2.7% on the week and the Nasdaq-100 5.0%, the worst week since June (Yahoo). Fear eased but did not go away: the VIX fear gauge fell 9% to 25.6, still above our alarm line of 25. Next week brings TSM's October sales (around Nov 10) and producer prices (Nov 13). NVDA reports on Nov 17.

The market by sector

S&P 500: day +0.3% · week −2.7% · month −5.0% · 3 mo −4.6%
SemiconductorsSMH
AI data-center build-out; China export rules
+3.6%
Emerging marketsEEM
The dollar, China, commodities
+2.2%
TechnologyXLK
AI spending; rates (profits far in the future)
+1.5%
Small companiesIWM
Rates and credit: they borrow at floating rates
+1.0%
CommunicationXLC
Ad spending (Google, Meta); their AI capex
+0.4%
IndustrialsXLI
Factory and data-center construction; defense
+0.1%
EnergyXLE
Oil and gas prices
0.0%
Consumer discretionaryXLY
Jobs, wages, rates; Amazon and Tesla
−0.1%
Health careXLV
Defensive; drug-price politics
−0.1%
SoftwareIGV
Company IT budgets; AI as threat and tool
−0.1%
UtilitiesXLU
Rates; now also AI power demand
−0.4%
FinancialsXLF
Yield curve, loan losses, deal activity
−0.6%
Real estateXLRE
Rates; data-center landlords
−0.7%
MaterialsXLB
China demand, the dollar, metal prices
−0.7%
Developed ex-USEFA
The dollar; Europe and Japan growth
−0.8%
Consumer staplesXLP
Defensive: people buy food in recessions
−1.3%

16 sector and region funds, total return as of the Nov 6 close. Strongest first.

How the pieces connect

  • Money flowed back into the AI trade for a day: chips +3.6%, emerging markets +2.2% (Taiwan and Korea are chip countries) and small companies +1.0%. It came out of the safe sectors that led all month: staples -1.3%, real estate -0.7%, financials -0.6%. Over a month the gap is still wide: chips -24% and tech -17% against health care +10% and staples +8%.
  • Strong jobs pushed bond yields up (10-year at 4.86%) and kept a December Fed hike near 73% likely. Higher rates hurt expensive growth stocks most, which is why the S&P gave back two thirds of its morning gain.
  • Credit is healing slowly but is still the light to watch. Junk bonds trail Treasuries by 2.5% over a month (3.0% on Thursday), and the junk-bond spread was 3.32 on Nov 4, down from 3.44 on Oct 30. AI companies borrow heavily to build data centers, so lenders are where an AI slowdown would spread beyond tech.
  • About 45% of our account sits in the AI-linked part of the market (ONEQ, MTUM, NVDA, TSM and the chip-heavy part of IEMG). We rise more than the S&P on bounce days like Friday and fall more on crack days like Thursday. This week that cost us 2.2 points against the S&P.

Rates, dollar, commodities, fear

10-year Treasury yield
4.86%
day +2bpmonth -37bp
Dollar index
102.30
day +0.7%month +0.2%
Oil (WTI)
$90.83
day +0.3%month −0.7%
Gold
$4,075
day −0.9%month −2.0%
Copper
$6.22
day −0.5%month −4.6%
VIX (fear gauge)
25.64
day −9.0%month +66.4%
Bitcoin
$75,802
day +0.1%month −6.9%

Early warning: 4 of 8 red

Chips cracking vs the S&P-18.6 pts; -18.0% vs 50-day1-month gap below -5 pts AND chips under their 50-day average
Market narrowing+3.3%Average stock trails the S&P by 3%+ over 3 months
Credit stress-2.5%Junk bonds trail Treasuries by 2%+ over a month
Fear25.6VIX above 25 (watch above 20)
Rates squeeze+16bp10-year yield up 40bp+ in 3 months
Dollar surge+2.5%Dollar up 5%+ in 3 months
Defensives taking over-2.5%Cyclicals trail defensives by 4%+ over a month
Nasdaq trend-9.0% vs 50-day; -3.5% vs 200-dayNasdaq-100 under its 200-day average (watch: under 50-day)

Information, not trade rules. Backtested 2000 to 2026: stepping aside when the chip light turns red lost 3.4 to 6.0 points a year after tax vs holding; half its alarms were false.

What the map says we can do

The account at the close

HoldingWeightDay
ONEQ Nasdaq Composite19.6%+1.1%
MTUM US momentum19.1%+1.8%
VOO S&P 50017.5%+0.3%
IEMG Emerging markets6.8%+2.1%
RSP S&P 500 equal weight6.8%−0.4%
IEFA Developed markets ex-US5.1%−0.7%
NVDA Nvidia3.2%+2.8%
TSM TSMC2.3%+6.3%
Cash Settling or waiting to be invested19.5%

Rules and how close they are

RuleFires atNow
NVDA automatic sell line$155.48$186.68, 20% abovewatch
Re-check any holding at -25% from cost-25%NVDA -16% (12% above its line); MTUM -9%, TSM -7%watch
Junk-bond spreads (credit stress)4.003.32 on Nov 4, 17% belowwatch
Nasdaq-100 trailing the S&P over 6 months15 points5.9 pointsclear
Dollar up over 6 months+5%+0.9%clear
Nasdaq fund (ONEQ) or momentum fund (MTUM) above 25% of the account25%19.6% and 19.1%clear
Any single foreign fund above 18%18%6.8% (IEMG)clear

Research

Halozyme (HALO), after its earnings

WATCH
Expected return +10.9% a yearBad case -34%

Halozyme earns royalties when big drug makers use its technology to turn IV drugs into quick shots under the skin. The quarter was strong: sales up 39%, royalties up 44%, full-year guidance raised, and none of our warning signs tripped. The stock still fell 15.7% to $103.68, and no news source explains why. Two risks the first memo missed: its patent fight with Merck is going its way in Europe but against it in the US until about 2028, and its biggest royalty (DARZALEX, 45% of royalties) steps down in 2029-30. Priced for those, and for its own worst patent scare (-48% in 2022-23), it returns about 10.9% a year, just under our 12% bar. It qualifies at $100 or lower. No trade.

Next

Sources: Robinhood (account, closes, filings), FRED (junk-bond spreads), Yahoo Finance, Schwab, Reuters, Halozyme (release, slides), The Motley Fool (call transcript).